1. Short-term myeloid reconstitution following TBI is not adversely affected by a dose of FK506 that abrogates lethal GVHD;Cooper;Bone Marrow Transplant,1994
2. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse events;Asante-Korang;J Heart Lung Transplant,1996
3. Red cell aplasia in children on tacrolimus after liver transplantation;Mirsa;Transplantation,1998
4. Pure red cell aplasia induced by FK506;Suzuki;Transplantation,1996
5. Acute hemolytic anemia in liver and bone marrow transplant patients under FK506 therapy;Abu-Elmagd;Transplant Proc,1991